Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 11156 clinical trials
Featured trial
Study title  

Study overview

  • 0 views
  • 05 May, 2021
  • 1 location
Featured trial
Trial T2  

QA Comment

  • 0 views
  • 05 Aug, 2021
  • 2 locations
Featured trial
Call center

Please add text here

Accepts healthy volunteers
  • 0 views
  • 04 Aug, 2023
  • 1 location
Featured trial
Demo test Trial  

Test Comment here..

Accepts healthy volunteers
  • 0 views
  • 14 Mar, 2022
  • 6 locations
Early Screening of Autism Spectrum Disorder in General and Pediatric Practices

The third Autism Plan in France then HAS 2018 Recommandations and The 2018 National Strategy for Autism have propose to implement three levels for early diagnostic : the frontline is constituted by professionals who can detect the firsts signs ( in nurseries, general practice, pediatric practice, early childhood centers), the …

autism
neurodevelopmental disorder
chat
csbs
pediatric
  • 0 views
  • 16 Feb, 2024
  • 1 location
Venglustat in Combination With Cerezyme in Adult and Pediatric Patients With Gaucher Disease Type 3

Cohort 3 Evaluate the efficacy of venglustat in combination with Cerezyme in adult and pediatric GD3 patients by assessing: CSF Lyso-GL1 levels Modified Friedreichs Ataxia Rating Scale - Activities of Daily Living (FARS-ADL) Brain resting-state functional Magnetic Resonance Imaging (rs-fMRI) reflecting connectivity between parieto-occipital areas Bone disease manifestations Evaluate safety …

  • 0 views
  • 04 Dec, 2020
  • 7 locations
Safety and Efficacy of Eliglustat With or Without Imiglucerase in Pediatric Patients With Gaucher Disease (GD) Type 1 and Type 3

Primary Objective: Evaluate the safety and pharmacokinetics of eliglustat in pediatric patients (2 to <18 years old). Secondary Objective: Evaluate the efficacy of eliglustat and quality of life in pediatric patients (2 to <18 years old).

osteopenia
replacement therapy
alglucerase
cerezyme
deficiency
  • 0 views
  • 04 Dec, 2020
  • 23 locations
Safety and Efficacy of Eliglustat With or Without Imiglucerase in Pediatric Patients With Gaucher Disease (GD) Type 1 and Type 3

Primary Objective: Evaluate the safety and pharmacokinetics of eliglustat in pediatric patients (2 to <18 years old). Secondary Objective: Evaluate the efficacy of eliglustat and quality of life in pediatric patients (2 to <18 years old).

osteopenia
replacement therapy
alglucerase
cerezyme
deficiency
  • 0 views
  • 04 Dec, 2020
  • 19 locations
Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

The study also includes as an observational objective to describe the safety profile of MenACYW conjugate vaccine and MENVEO when administered concomitantly with routine pediatric vaccines in healthy infants and toddlers.

  • 0 views
  • 04 Dec, 2020
  • 47 locations
Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the Russian Federation and Mexico

Primary Objective: To describe the antibody titers to the antigens (meningococcal serogroups A, C, Y, and present in MenACYW conjugate vaccine or Menveo measured by serum bactericidal assay using human complement (hSBA), for Groups 1 and 2 when administered concomitantly with routine pediatric vaccines in healthy infants and toddlers in …

  • 0 views
  • 08 Dec, 2020
  • 9 locations